According to Kefu Medical's announcement, the company reviewed and passed a bill to change the use of 397,000 A-shares in the 2022 repurchase plan, changing the use of part of the shares from “to implement employee stock ownership plans or equity incentives” to “use to cancel and reduce registered capital.” After the cancellation is completed, the total share capital and registered capital of the company will be reduced by 397,000 yuan accordingly. The company has notified creditors of this capital reduction. Within 45 days from the date of disclosure of the announcement, creditors have the right to demand settlement of debts or provision of corresponding guarantees from the company with valid proof of claim documents. Failure to file an overdue declaration does not affect the validity of the claim.

According to Kefu Medical's announcement, the company reviewed and passed a bill to change the use of 397,000 A-shares in the 2022 repurchase plan, changing the use of part of the shares from “to implement employee stock ownership plans or equity incentives” to “use to cancel and reduce registered capital.” After the cancellation is completed, the total share capital and registered capital of the company will be reduced by 397,000 yuan accordingly. The company has notified creditors of this capital reduction. Within 45 days from the date of disclosure of the announcement, creditors have the right to demand settlement of debts or provision of corresponding guarantees from the company with valid proof of claim documents. Failure to file an overdue declaration does not affect the validity of the claim.